XAGE Longevity Health Holdings, Inc.
Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics · OTC · SEC CIK 1842939 · Fiscal year ends 12/31
Financial factors as of 2026-06-30 (2026Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY60.3%
TTM net income YoY5.0%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin59.0%
Operating margin-343.6%
Net margin-404.8%
FCF margin—
EBITDA margin-340.0%
Returns
ROE—
ROA-286.0%
ROIC (approx.)—
Asset turnover0.71x
Leverage & solvency
Liabilities / assets924.4%
Debt / equity—
Current ratio0.07x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.36x
Accruals ratio-183.4%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 | 2024Q32024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $395,991 | $391,764 | $472,982 | $425,864 | $503,612 | $510,353 | $17,479 | $20,519 |
| Cost of revenue | $160,455 | $154,739 | $205,166 | $171,401 | $200,954 | $240,530 | $1,225 | $4,840 |
| Gross profit | $235,536 | $237,025 | $267,816 | $254,463 | $302,658 | $269,823 | $16,254 | $15,679 |
| R&D expense | $73,351 | $55,488 | $104,080 | $227,993 | $228,606 | $196,912 | $189,018 | $331,806 |
| SG&A expense | $681,559 | — | — | — | $1.56M | — | — | — |
| Operating income | -$724,150 | -$1.33M | -$2.27M | -$1.47M | -$1.86M | -$1.51M | -$1.01M | -$1.42M |
| Interest expense | — | $3,450 | $5,601 | $5,059 | $2,561 | $4,993 | $7,493 | $7,123 |
| Pretax income | -$1.88M | -$1.43M | -$2.05M | -$1.43M | -$1.89M | -$1.51M | -$1.01M | -$2.88M |
| Income tax | $0 | $0 | $36,262 | $0 | $0 | $0 | -$97,279 | $0 |
| Net income | -$1.88M | -$1.43M | -$2.08M | -$1.43M | -$1.89M | -$1.51M | -$914,283 | -$2.88M |
| EBITDA | -$710,812 | -$1.31M | -$2.25M | -$1.45M | -$1.84M | -$1.48M | -$988,430 | -$1.40M |
| EPS (basic) | -0.76 | -0.75 | — | -0.83 | -1.56 | -1.52 | — | -4.13 |
| EPS (diluted) | — | -0.75 | — | -0.83 | -1.56 | -1.52 | — | -4.13 |
| Weighted avg. shares (diluted) | — | 1.90M | — | 1.72M | 1.21M | 991,210 | — | 696,847 |
| Balance sheet | ||||||||
| Cash & equivalents | $35,471 | $313,396 | $706,740 | $1.11M | $1.55M | $770,047 | $157,139 | $1.14M |
| Receivables | $19,546 | $48,665 | $36,500 | $46,522 | $54,496 | $94,753 | $4,096 | — |
| Inventory | $606,668 | $734,968 | $963,028 | $1.01M | $1.17M | $1.38M | $108,705 | $97,890 |
| Current assets | $711,716 | $1.26M | $1.95M | $2.84M | $3.24M | $2.79M | $955,554 | $1.88M |
| PP&E, net | $75,517 | $87,719 | $101,621 | $116,754 | $117,662 | $138,709 | $113,906 | $131,216 |
| Intangibles | $12,822 | $13,958 | $15,094 | $16,231 | $17,367 | $18,504 | $19,641 | $20,778 |
| Total assets | $1.06M | $1.64M | $2.37M | $3.30M | $3.72M | $3.34M | $1.47M | $2.44M |
| Current liabilities | $9.59M | $8.35M | $7.92M | $6.84M | $6.91M | $6.60M | $5.88M | $6.17M |
| Total liabilities | $9.75M | $8.54M | $8.23M | $7.28M | $7.46M | $7.14M | $6.19M | $6.51M |
| Shareholders' equity | -$8.70M | -$6.89M | -$5.87M | -$3.98M | -$3.74M | -$3.81M | -$4.71M | -$4.06M |
| Shares outstanding | 2.48M | 2.48M | 1.78M | 1.78M | 1.48M | 1.00M | 696,969 | 20.91M |
| Cash flow statement | ||||||||
| Operating cash flow | -$223,881 | -$485,291 | -$306,367 | -$1.43M | -$836,190 | -$752,953 | -$772,063 | -$1.40M |
| Capital expenditure | — | — | $1 | — | — | — | — | — |
| Free cash flow | — | — | -$306,368 | — | — | — | — | — |
| Investing cash flow | — | — | -$1 | $776 | -$15,000 | -$150,000 | $0 | $0 |
| Financing cash flow | -$54,044 | $91,947 | -$96,120 | $991,009 | $1.63M | $1.52M | -$208,123 | $341,681 |
| Depreciation & amortization | $13,338 | $15,038 | $16,271 | $16,268 | $22,184 | $23,952 | $18,447 | $17,978 |
| Stock-based compensation | $78,759 | $145,927 | $193,712 | $189,926 | $194,323 | $114,829 | $266,178 | $185,696 |
Free plan shows the latest 8 periods; Pro shows all 21 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.